P. Pujol

发表

Semiquantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the oestrogen pathway.

T. Maudelonde, P. Callier, G. Freiss, 2000, Journal of molecular endocrinology.

Expression of oestrogen receptor-alpha splicing variants and oestrogen receptor-beta in endometrium of infertile patients.

T. Maudelonde, B. Hédon, H. Déchaud, 1998, Molecular human reproduction.

[Anti-estrogens, selective estrogen receptor modulators (SERM), tibolone: modes of action].

T. Maudelonde, J. Brouillet, P. Pujol, 1999, Contraception, fertilite, sexualite.

Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.

C. Lejeune, R. Boidot, J. Thevenon, 2019, European journal of medical genetics.

Analysis of the potential contribution of estrogen receptor (ER) β in ER cytosolic assay of breast cancer

P. Lamy, T. Maudelonde, D. Chalbos, 2001, International journal of cancer.

p53 mutations in ovarian cancer: a late event?

T. Maudelonde, C. Theillet, P. Jeanteur, 1991, Oncogene.

A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma

J. Bringer, J. Daurès, T. Maudelonde, 2001, Cancer.

Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer

J. Daurès, T. Maudelonde, H. Rochefort, 1999, British Journal of Cancer.

In vivo stimulation by tamoxifen of cathepsin D RNA level in breast cancer.

T. Maudelonde, H. Rochefort, J. Brouillet, 1994, European journal of cancer.

Neoadjuvant tamoxifen for operable breast cancer: a need for phase III studies?

J. Daurès, T. Maudelonde, J. Hermand, 2000, Cancer detection and prevention.